All In MedTech

Device Trial Radar · NCT03382652

Continuum™ Metal Bearing System in Total Hip Arthroplasty

Continuum™ Metal Bearing System in Total Hip Arthroplasty- A Multi-center, Prospective, Non-controlled Post Market Surveillance Study

Last checked: Nov 21, 2026Latest source record: Jan 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

83

Actual

Start

Feb 9, 2011

Primary completion

Oct 22, 2022

Study completion Oct 22, 2022

Sponsor

Lead sponsor
Zimmer BiometPublic (ZBH)
Sponsor type
Industry
First posted
Dec 26, 2017

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is a multi-center, prospective, non-controlled, consecutive cohort post market surveillance study. The objective of this study is to obtain survival and outcome data on the Continuum Metal Bearing System in primary total hip arthroplasty.

Conditions

  • Avascular Necrosis
  • Osteoarthritis
  • Inflammatory Arthritis
  • Post-traumatic; Arthrosis
  • Total Hip Arthroplasty

Interventions

  • Metal-on-Metal ArticulationDevice

    \<Metal-on-Metal Articulation\>: Metasul® Taper Liner and Metasul Femoral Head, \<Acetabular Component\>:Continuum Acetabular Shell, \<Femoral Component\>: Zimmer® M/L Taper Hip Stem

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Implant Survival at 10 YearsTime frame: 1, 2, 3, 5, 7, and 10 years postop.

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • Saint Davids Medical Center

    Austin, Texas

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.